NCT03772977Active, not recruiting
The Brain Health Champion Study
The Brain Health Champion Study: Promoting Non-pharmacological Interventions in Cognitive Disorders and Those at Risk
Source: ClinicalTrials.gov · Last updated 10 Jul 2026
Brief summary (registry, in English)
6-month, randomized, controlled investigation measuring the effect of increased clinical contact and personalization compared to standard physician counseling on adherence to consensus-based, brain health recommendations for patients with subjective cognitive decline, mild cognitive impairment, and early dementia or patients who are at risk for developing these conditions.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 95 (estimated)
- First submitted
- 25 Nov 2018
- Start date
- 8 May 2017
- Primary completion date
- 1 Jul 2024
- Lead sponsor
- Brigham and Women's Hospital
- NCT number
- NCT03772977
What you commit to
- Study type: Interventional
- Planned participants: 95
- From 8 May 2017 to the primary completion date, 1 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Be enrolled in another health behavior or non-pharmacologic intervention for a neurocognitive disorder
Other
- Be unable to or unwilling to carry out regular physical exercise, multiple times weekly.
- Be not recommended to participate by their Internist/Primary Care Provider due to health-related concerns.
Who the study is looking for
- Be age 60 to 79
- Existing patient at Brigham Health system with at least one prior visit with providers and plans to establish/continue longitudinal care
- Be sufficiently fluent in the English language to understand instructions and perform the cognitive and functional tests
- For neurology participants only: Have a diagnosis of Subjective Cognitive Disorder (SCD) (MMSE guideline 27-30), Mild Cognitive Impairment (MCI) due to Alzheimer disease (AD), cerebrovascular disease (CVD), or mixed-type AD/CVD (MMSE guideline 24-30), or mild dementia due to AD, CVD, or mixed-AD/CVD (MMSE guideline 20-30). In some cases, based on the clinical judgment of the treating neurologist, we may enroll a patient who falls outside of these guidelines or whose diagnosis and overall level of functioning does not perfectly correlate to their MMSE score.
- For primary care participants only: Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) dementia risk score of ≥ 6, or score of 5 plus one of the following: a history of ADRD in a first-degree relative, or type II diabetes or "pre-diabetes" spectrum (A1C level ≥ 5.7)
Age in the registry: 60 years to 79 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Brigham and Women's Hospital Department of Neurology Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.